Effect of fingolimod on circulating B cells in patients with multiple sclerosis

被引：0
|
作者：
Miyazaki, Y. [1 ]
Niino, M. [1 ]
Fukazawa, T. [2 ]
Nonaka, T. [1 ]
Amino, I. [1 ]
Tashiro, J. [1 ]
Minami, N. [1 ]
Fujiki, N. [1 ]
Doi, S. [1 ]
Kikuchi, S. [1 ]
机构：
[1] Hokkaido Med Ctr, Sapporo, Hokkaido, Japan
[2] Sapporo Neurol Clin, Sapporo, Hokkaido, Japan
来源：
MULTIPLE SCLEROSIS JOURNAL | 2013年 / 19卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：217 / 217
页数：1
相关论文
共 50 条
  • [31] Fingolimod Increases Brain-Derived Neurotrophic Factor Level Secretion from Circulating T Cells of Patients with Multiple Sclerosis
    Golan, Maya
    Mausner-Fainberg, Karin
    Ibrahim, Bassima
    Benhamou, Moshe
    Wilf-Yarkoni, Adi
    Kolb, Hadar
    Regev, Keren
    Karni, Arnon
    CNS DRUGS, 2019, 33 (12) : 1229 - 1237
  • [32] Fingolimod Treatment Reduces Circulating CD4+ Regulatory T Cells and Th17 Cells in Blood of Patients with Multiple Sclerosis
    Brinkmann, Volker
    Raulf, Friedrich
    Vedrine, Corinne
    Allard, Cyril
    NEUROLOGY, 2012, 78
  • [33] Effect of fingolimod (FTY720) on choroidal thickness in patients with multiple sclerosis
    Kal, Ali
    Ulusoy, Mahmut Oguz
    Horasanli, Bahriye
    Cezairlioglu, Sefik
    Kal, Oznur
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2017, 14 : 4 - 7
  • [34] Effect of Fingolimod-Treatment on Blood Lipid Profiles of Multiple Sclerosis Patients
    Hovi, Anni
    Airas, Laura
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2016, 11 (04) : 611 - 612
  • [35] Myeloid cells as target of fingolimod action in multiple sclerosis
    Di Dario, Marco
    Colombo, Emanuela
    Govi, Chiara
    De Feo, Donatella
    Messina, Maria Jose
    Romeo, Marzia
    Sangalli, Francesca
    Moiola, Lucia
    Rodegher, Mariaemma
    Martino, Gianvito
    Martinelli, Vittorio
    Comi, Giancarlo
    Farina, Cinthia
    NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION, 2015, 2 (06):
  • [36] Fingolimod effect on gray matter, thalamus, and white matter in patients with multiple sclerosis
    Gaetano, Laura
    Haering, Dieter A.
    Radue, Ernst-Wilhelm
    Mueller-Lenke, Nicole
    Thakur, Avinash
    Tomic, Davorka
    Kappos, Ludwig
    Sprenger, Till
    NEUROLOGY, 2018, 90 (15) : E1324 - E1332
  • [37] Effect of Fingolimod-Treatment on Blood Lipid Profiles of Multiple Sclerosis Patients
    Anni Hovi
    Laura Airas
    Journal of Neuroimmune Pharmacology, 2016, 11 : 611 - 612
  • [38] Fingolimod therapy modulates circulating B cell composition, increases B regulatory subsets and production of IL-10 and TGFβ in patients with Multiple Sclerosis
    Blumenfeld, Shiri
    Staun-Ram, Elsebeth
    Miller, Ariel
    JOURNAL OF AUTOIMMUNITY, 2016, 70 : 40 - 51
  • [39] Restoration of aberrant circulating miRNAs levels after fingolimod treatment in patients with relapsing remitting multiple sclerosis
    Calvi, A.
    Fenoglio, C.
    De Riz, M.
    Pietroboni, A. M.
    Ghezzi, L.
    Maltese, V.
    Serpente, M.
    Bonsi, R.
    Barone, C.
    Cioffi, S.
    Frigerio, F.
    Turrini, R.
    Galimberti, D.
    Scarpini, E.
    EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 : 341 - 341
  • [40] Restoration of aberrant circulating miRNAs levels after fingolimod treatment in patients with relapsing remitting multiple sclerosis
    Calvi, A.
    Fenoglio, C.
    De Riz, M.
    Pietroboni, A. M.
    Ghezzi, L.
    Maltese, V.
    Serpente, M.
    Bonsi, R.
    Barone, C.
    Cioffi, S.
    Frigerio, F.
    Turrini, R.
    Galimberti, D.
    Scarpini, E.
    JOURNAL OF NEUROLOGY, 2014, 261 : S230 - S230
12345